Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 870 participants.

Also called NCT01340768

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 870 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01340768
  • CTRI CTRI/2011/06/001838
Other papers using this trial's data
  • Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study Current medical research and opinion, 2012-08 DOI, PubMed 22738801

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01340768. Randomized; no masking; primary purpose treatment. Start 2010-06-22 (actual); primary completion 2011-09-21 (actual). Results posted on 2012-10-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Sulfonylurea
Intervention (Drug)
Metformin
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct01340768
Content hash
d31afdc272894bc5193c73f9258b40726da9ef86219b8efebeab0a2436ccece1